Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

10 Feb 2026 - 13 Feb 2026
17 Apr 2026 - 21 Apr 2026

Gene Panel May Be Able to Identify Existing and Potential Alcoholics

By LabMedica International staff writers
Posted on 02 Jun 2014
A Convergent Functional Genomics (CFG) approach was used to discover genes involved in alcoholism in a study that has implications for genetic testing to assess risk for developing an illness before the illness manifests itself clinically.

The CFG technique was developed by Dr. More...
Alexander Niculescu of the Indiana University School of Medicine (Indianapolis, USA), and collaborators starting in 1999. It is an approach for identifying and prioritizing candidate genes and biomarkers for complex psychiatric and medical disorders by integrating and tabulating multiple lines of evidence including gene expression and genetic data from human studies and from animal model work. CFG generates a signal that is predictive and is reproducible in independent studies, as opposed to the fit-to-cohort aspect of classic human genetic studies like the genome-wide association study (GWAS), where the issue of genetic heterogeneity makes the top statistically significant findings from even large size studies less reproducible in independent studies.

In the current work, Dr. Niculescu and collaborators in the United States and Germany used CFG to analyze data from a German genome-wide study of alcoholism and data from a variety of other studies into genetic links to alcoholism. The analysis produced a group of 135 candidate genes. They then used a stress-reactive animal model of alcoholism, the D-box binding protein (DBP) knockout mouse, to identify genes expressed by both the alcoholic humans and the stress-reactive alcoholic mice.

This process yielded a panel of 11 genes with 66 single-nucleotide polymorphisms (SNPs). The investigators found that this panel of 11 genes could be used to differentiate between alcoholics and non-alcoholics in three different research populations for which genetic data and information about alcohol consumption were available: a group of Caucasian subjects and a group of African American subjects from the USA, and a third group from Germany.

"This powerful panel of just 11 genes successfully identified who has problems with alcohol abuse and who does not in tests in three patient populations on two continents, in two ethnicities and in both genders," said senior author Dr. Alexander B. Niculescu, associate professor of psychiatry and medical neuroscience at the Indiana University School of Medicine. "We believe this is the strongest result to date in the field of alcoholism and offers a comprehensive—though not exhaustive—window to the genetics and biology of alcoholism."

The study was published in the May 20, 2014, issue of the journal Translational Psychiatry.

Related Links:

Indiana University School of Medicine



Gold Member
Immunochromatographic Assay
CRYPTO Cassette
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Alcohol Testing Device
Dräger Alcotest 7000
Gold Member
Collection and Transport System
PurSafe Plus®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.